• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Advisory Committees

  • Print
  • Share
  • E-mail

Briefing Information for the March 28-29, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee

 

 
Persons with disabilities having problems accessing the PDF file(s) below may call (301) 796-3634 for assistance
 
FDA
 
Disclaimer
 
Portions of this document have been determined to be exempt from disclosure under the Freedom of Information Act (the FOIA) (5 U.S.C. § 552)
 
FDA Briefing Information for the March 28-29, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (PDF - 170KB)
 
Errata to the FDA Briefing Information for the March 28-29, 2012 Meeting of the Endocrinologic and Metabolic Drugs Advisory Committee (PDF - 33KB)